Shionogi To Buy U.S. Specialty Drug Maker Victory Pharma
This article was originally published in PharmAsia News
Executive Summary
Shionogi's U.S. unit Sciele Pharma announced a plan to pay $150 million to acquire Victory Pharma, a U.S. pharmaceutical company specializing in pain drugs. The deal is expected to complete next month. The addition of Victory will further strengthen Shionogi's presence in the pain market, which has been one of the target therapeutic areas for the company. Shionogi also plans to introduce new products through Sciele. (Click here for more - Japanese language